Elevra Lithium September 2026 Quarterly Report Advisory
BRISBANE, Australia, Oct. 20, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (ASX:ELV; NASDAQ:ELVR) (“Elevra” or “Company”) advises that the Company’s September 2026 Quarterly Activities Report is scheduled for release on Tuesday, 27 October 2026.
Covered in this story
Analyst targets on Elevance Health
- Guggenheim: $421 → $460 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ELV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Elevance Health →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.